Ann M. Hanly is EVP & Chief Technology Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 132,069 shares of VIR, which is worth approximately $986,555. The most recent transaction as insider was on Apr 01, 2024, when has been sold 2,711 shares (Common Stock) at a price of $10.05 per share, resulting in proceeds of $27,245. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K
0% 3M change
15.27% 12M change
Total Value Held $986,555

ANN M. HANLY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
SELL
Open market or private sale
$27,245 $10.05 p/Share
2,711 Reduced 2.01%
132,069 Common Stock
Feb 22 2024
SELL
Open market or private sale
$123,574 $10.05 p/Share
12,296 Reduced 8.36%
134,780 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
32,500 Added 18.1%
147,076 Common Stock
Mar 30 2023
SELL
Open market or private sale
$59,816 $22.77 p/Share
2,627 Reduced 2.24%
114,576 Common Stock
Feb 23 2023
SELL
Open market or private sale
$59,782 $25.97 p/Share
2,302 Reduced 1.93%
117,203 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
37,500 Added 23.88%
119,505 Common Stock
Mar 30 2022
SELL
Open market or private sale
$68,932 $26.24 p/Share
2,627 Reduced 3.12%
81,473 Common Stock
Feb 22 2022
BUY
Grant, award, or other acquisition
-
53,500 Added 38.88%
84,100 Common Stock
Mar 29 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 50.0%
30,000 Common Stock
AMH

Ann M. Hanly

EVP & Chief Technology Officer
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR